Case Reports
doi: 10.2169/internalmedicine.43.131.
Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab
Affiliations
- PMID: 15005256
- DOI: 10.2169/internalmedicine.43.131
Item in Clipboard
Case Reports
Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab
Intern Med.
2004 Feb.
Free article
Abstract
We report a 72-year-old man with Waldenström's macroglobulinemia (WM) in whom diffuse large B-cell lymphoma (DLCL) occurred 17 years after the diagnosis of WM. The malignant cells of both DLCL and WM expressed CD20 on their surface. CHOP plus anti-CD20 monoclonal antibody, rituximab, were effective for both diseases, and the patient remains disease-free 17 months later.
Similar articles
-
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.Leuk Lymphoma. 2007 Feb;48(2):431-3. doi: 10.1080/10428190601059704. Leuk Lymphoma. 2007. PMID: 17325912 No abstract available.
-
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795. N Engl J Med. 2002. PMID: 11807147 Clinical Trial.
-
Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.Hematol Oncol Clin North Am. 2018 Oct;32(5):821-827. doi: 10.1016/j.hoc.2018.05.009. Epub 2018 Jul 25. Hematol Oncol Clin North Am. 2018. PMID: 30190020 Review.
-
Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation.Int J Hematol. 2010 Sep;92(2):391-7. doi: 10.1007/s12185-010-0638-1. Epub 2010 Aug 5. Int J Hematol. 2010. PMID: 20686877
-
Rituximab-based treatments in Waldenström's macroglobulinemia.Clin Lymphoma Myeloma. 2009 Mar;9(1):59-61. doi: 10.3816/CLM.2009.n.015. Clin Lymphoma Myeloma. 2009. PMID: 19362975 Review.
Cited by
-
Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms.Hematol Rep. 2011 Aug 31;3(2):e10. doi: 10.4081/hr.2011.e10. Epub 2011 Aug 30. Hematol Rep. 2011. PMID: 22184531 Free PMC article.
-
Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report.World J Clin Cases. 2022 Aug 6;10(22):7994-8002. doi: 10.12998/wjcc.v10.i22.7994. World J Clin Cases. 2022. PMID: 36158496 Free PMC article.
-
Update on therapeutic options in Waldenström macroglobulinemia.Eur J Haematol. 2009 Jan;82(1):1-12. doi: 10.1111/j.1600-0609.2008.01171.x. Eur J Haematol. 2009. PMID: 19087134 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
